0370 1500 100

Family Pay Tribute To Father Following Asbestos-Related Death

Former Postman, Alan Morley, Died From Mesothelioma


The family of a former postman who died from mesothelioma, a relatively rare form of cancer linked to exposure to asbestos, have paid tribute to him.

Alan Morley, 64, who died on July 12th, was diagnosed with mesothelioma, which affected the lining of his lungs, in March, the Sleaford Target reports.

Symptoms of mesothelioma usually develop 10-50 years after exposure to the substance, with sufferers living an average of 9-14 months following diagnosis. The most recent Health and Safety Executive statistics indicate that around 2,500 people are diagnosed with mesothelioma every year.

His sister, Gill Hubbard, said Alan would always go out of his way to help others and the people on his rounds loved him. Alan’s daughter Hannah said her father’s bravery and courage was an “inspiration”.

His family said his illness came on suddenly and they are unaware where he came into contact with asbestos fibres or dust. During his 37 years as a postman he worked on rounds in Great Hale, Little Hale, Helpringham and Sleaford town centre.

Expert Opinion
Mesothelioma is a very aggressive and incurable cancer which causes a great deal of distress to victims like Alan. In cases like this it can be very difficult for victims and their families to recall how and when they came into contact with asbestos, due to the long period between exposure and the onset of symptoms.

"Sadly many people were let down by their employers, who knew about the dangers of asbestos containing materials, and this case yet again highlights the devastating impact exposure to the deadly substance can have many years down the line.

“Through our work in cases similar to Alan’s, we have seen the terrible effects exposure to asbestos dust and fibres can have on victims, their family and friends and the local community.”
Adrian Budgen, Partner

© 2017 Irwin Mitchell LLP is Authorised & Regulated by the Solicitors Regulation Authority. Our Regulatory Information.